In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
about
The role of small molecules in musculoskeletal regeneration.CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation.Studies of bone morphogenetic protein-based surgical repair.Periostin Upregulates Wnt/β-Catenin Signaling to Promote the Osteogenesis of CTLA4-Modified Human Bone Marrow-Mesenchymal Stem Cells.Angiogenesis and bone regeneration of porous nano-hydroxyapatite/coralline blocks coated with rhVEGF165 in critical-size alveolar bone defects in vivoTacrolimus treatment increases bone formation in patients with rheumatoid arthritis.
P2860
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
@en
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate
@nl
type
label
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
@en
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate
@nl
prefLabel
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
@en
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate
@nl
P2093
P356
P1433
P1476
In vitro bone formation induced by immunosuppressive agent tacrolimus hydrate (FK506).
@en
P2093
Akitaka Nonomura
Hiroshi Nakajima
Takafumi Yoshikawa
Takahiko Kasai
Tomomi Tamura
Toshimasa Uemura
Yasunori Enomoto
Yoshinori Takakura
P304
P356
10.1089/TEN.2005.11.609
P577
2005-03-01T00:00:00Z